Results 221 to 230 of about 64,777 (328)

Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts [PDF]

, 2008
Georg Feldmann, Anirban Maitra
openalex   +1 more source

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas [PDF]

, 2008
Heike Immervoll, Dag Hoem, Per Øystein Sakariassen, Ole Steffensen, Anders Molven   +4 more
openalex   +1 more source

Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe

Journal of Biophotonics, EarlyView.
The efficient discrimination of a hepatic cancer lesion and its surgical margin using autofluorescence lifetime imaging is presented. White light image of the specimen on the left and the augmented image with fluorescence lifetime data on the right.
D. Suraci, E. Baria, L. Tirloni, J. L. Lagarto, S. Buccianti, C. Agostini, S. Pillozzi, L. Antonuzzo, A. Taddei, R. Cicchi   +9 more
wiley   +1 more source

ABERRANT ADAM17/TACE EXPRESSION AS POTENTIAL “LATE EVENT” IN THE DEVELOPMENT OF HUMAN DUCTAL PANCREATIC ADENOCARCINOMA.

, 2004
Jörg Ringel, Jütta Lüttges, Ralf Jesenowski, SK Batra, Matthias Löhr   +4 more
openalex   +1 more source

Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma [PDF]

, 2008
Justin Cates, Robert H. Byrd, Laurel E. Fohn, Armanda Tatsas, M. Kay Washington, Candice C. Black   +5 more
openalex   +1 more source

Comparable impact of lymph node metastases in T2 gallbladder cancer on postoperative prognosis irrespective of the extent of the metastases: A retrospective analysis

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background Lymph node metastases beyond the hepatoduodenal ligament are sometimes encountered in locally limited T2 gallbladder cancer (GBCA). However, the incidence and impact on prognosis remain unclear. Methods This was a retrospective multi‐institutional study of patients who underwent surgical resection for GBCA from 2002 to 2022.
Yoji Kishi, Teiichi Sugiura, Takashi Mizuno, Hiromichi Ito, Yu Takahashi, Takehiro Noji, Yuta Abe, Shimpei Otsuka, Shoji Kawakatsu, Asayo Kato, Masayuki Tanaka, Tomoki Ebata, Satoshi Hirano   +12 more
wiley   +1 more source

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

, 2005
Sunil R. Hingorani, Lifu Wang, Asha S. Multani, Chelsea Combs, Thérèse B. Deramaudt, Ralph H. Hruban, Anil K. Rustgi, Sandy Chang, David A. Tuveson   +8 more
openalex   +1 more source

Carbon‐ion irradiation together with autophagy inhibition and immune checkpoint inhibitors protect against pancreatic cancer development in mouse model

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background Pancreatic cancer remains fatal because of resistance to chemo‐, radio‐, and immunotherapies. Carbon‐ion radiotherapy (CIRT) has been beneficial for patients with pancreatic cancer. The purpose of this study was to identify the mechanism by which CIRT exerts its anticancer activity, particularly in combination with immunotherapy ...
Makoto Sudo, Yaoyao Wang, Jingren Wang, Koubun Yasuda, Keiko Mitani, Shuhei Hayashi, Masaki Ohmuraya, Hiroko Tsutsui, Jiro Fujimoto   +8 more
wiley   +1 more source

How I Treat Pancreatic Ductal Adenocarcinoma [PDF]

, 2008
Margaret A. Tempero
openalex   +1 more source